Immix Biopharma (IMMX) Tax Provisions (2021 - 2025)
Immix Biopharma's (IMMX) quarterly Tax Provisions came in at $11266.0 in Q4 2025, up 4.46% year-on-year from $10785.0 in Q4 2024, and up 45.89% quarter-over-quarter from $7722.0 in Q3 2025.
Immix Biopharma (IMMX) Tax Provisions (2021 - 2025) Analysis & Trends
Immix Biopharma has disclosed Tax Provisions across 5 years of filings, most recently posting $11266.0 for Q4 2025.
- Tax Provisions for Q4 2025 came in at $11266.0, up 4.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $37724.0 (down 8.07% YoY), and the FY2025 annual result was $37724.0, down 8.07% from the prior year.
- Tax Provisions came in at $11266.0 for Q4 2025 at Immix Biopharma, up from $7722.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11266.0 in Q4 2025 to a low of $1337.0 in Q3 2021.
- The 5-year median for Tax Provisions is $6578.0 (2023), against an average of $6072.8.
- Across the five-year window, Tax Provisions surged 307.12% in 2023 and sank 30.71% in 2025, its largest moves.
- Immix Biopharma's Tax Provisions stood at $1477.0 in 2021, then soared by 256.06% to $5259.0 in 2022, then surged by 53.81% to $8089.0 in 2023, then surged by 33.33% to $10785.0 in 2024, then grew by 4.46% to $11266.0 in 2025.
- The last three Tax Provisions figures came in at $11266.0 (Q4 2025), $7722.0 (Q3 2025), and $8914.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,266.00 |
| Sep 30, 2025 | 7,722.00 |
| Jun 30, 2025 | 8,914.00 |
| Mar 31, 2025 | 9,822.00 |
| Dec 31, 2024 | 10,785.00 |
| Sep 30, 2024 | 11,144.00 |
| Jun 30, 2024 | 10,269.00 |
| Mar 31, 2024 | 8,839.00 |
| Dec 31, 2023 | 8,089.00 |
| Sep 30, 2023 | 6,807.00 |
| Jun 30, 2023 | 6,349.00 |
| Mar 31, 2023 | 5,170.00 |
| Dec 31, 2022 | 5,259.00 |
| Sep 30, 2022 | 1,672.00 |
| Jun 30, 2022 | 1,715.00 |
| Mar 31, 2022 | 1,622.00 |
| Dec 31, 2021 | 1,477.00 |
| Sep 30, 2021 | 1,337.00 |
| Jun 30, 2021 | 1,608.00 |
| Mar 31, 2021 | 1,591.00 |